Emily E. Thornton

Emily E. Thornton

Auto-generated profile, based on publicly available information

Emily E. Thornton

Department of Pathology, University of California, San Francisco, San Francisco, CA 94143, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2013 in Nature
Verified
Journal Article
Open access
PDF file
JNJesse C. Nussbaum
Jesse C. Nussbaum
SDSteven J. Van Dyken
Steven J. Van Dyken
JMJakob von Moltke
Jakob von Moltke
LCLaurence E. Cheng
Laurence E. Cheng
AMAlexander Mohapatra
Alexander Mohapatra
RLRichard M. Locksley
Richard M. Locksley
Eosinophil recruitment to the lung and intestine is regulated by type-2-innate-lymphoid-cell-derived IL-5 and IL-13; IL-5 is shown to be induced by the neuropeptide vasoactive intestinal peptide, which is known to coordinate pancreatic secretion with smooth muscle relaxation in response to feeding. Interleukin-5 (IL-5) is required for bone marrow eosinophil production, whereas IL-13 induces chemoattractant proteins known as eotaxins that recruit eosinophils into inflamed tissue. Richard Locksley and colleagues use a mouse strain that permits fate mapping and deletion of IL-5-producing cells to demonstrate that eosinophil recruitment to the lung and intestine is regulated by type 2 innate lymphoid cell-derived IL-5 and IL-13. IL-5 is induced by vasoactive intestinal peptide, which is known to coordinate pancreatic secretion with smooth muscle relaxation in response to feeding. These findings link eosinophils to basal circadian oscillations through long-lived type 2 innate lymphoid cell activation. Eosinophils are specialized myeloid cells associated with allergy and helminth infections. Blood eosinophils demonstrate circadian cycling, as described over 80 years ago1, and are abundant in the healthy gastrointestinal tract. Although a cytokine, interleukin (IL)-5, and chemokines such as eotaxins mediate eosinophil development and survival2, and tissue recruitment3, respectively, the processes underlying the basal regulation of these signals remain unknown. Here we show that serum IL-5 levels are maintained by long-lived type 2 innate lymphoid cells (ILC2) resident in peripheral tissues. ILC2 cells secrete IL-5 constitutively and are induced to co-express IL-13 during type 2 inflammation, resulting in localized eotaxin production and eosinophil accumulation. In the small intestine where eosinophils and eotaxin are constitutive4, ILC2 cells co-express IL-5 and IL-13; this co-expression is enhanced after caloric intake. The circadian synchronizer vasoactive intestinal peptide also stimulates ILC2 cells through the VPAC2 receptor to release IL-5, linking eosinophil levels with metabolic cycling. Tissue ILC2 cells regulate basal eosinophilopoiesis and tissue eosinophil accumulation through constitutive and stimulated cytokine expression, and this dissociated regulation can be tuned by nutrient intake and central circadian rhythms.

15 April 2013 in Journal of Experimental Medicine
Verified
Journal Article
Open access
SKStefanie Kirchberger
Stefanie Kirchberger
DRDaniel J. Royston
Daniel J. Royston
OBOlivier Boulard
Olivier Boulard
ETEmily Thornton
Emily Thornton
FFFanny Franchini
Fanny Franchini
FPFiona Powrie
Fiona Powrie
Patients with inflammatory bowel disease (IBD) have an increased risk of colon cancer. However, the immune cells and cytokines that mediate the transition from intestinal inflammation to cancer are poorly understood. We show that bacteria-induced colon cancer is accompanied by differential accumulation of IL-17+IL-22+ colonic innate lymphoid cells (cILCs), which are phenotypically distinct from LTi and NK-22 cells, and that their depletion in mice with dysplastic inflammation blocks the development of invasive colon cancer. Analysis of the functional role of distinct Type 17 cytokines shows that although blockade of IL-17 inhibits some parameters of intestinal inflammation, reduction in dysplasia and colorectal cancer (CRC) requires neutralization of IL-22 indicating a unique role for IL-22 in the maintenance of cancer in this model. Mechanistic analyses showed that IL-22 selectively acts on epithelial cells to induce Stat3 phosphorylation and proliferation. Importantly, we could detect IL-22+CD3+ and IL-22+CD3− cells in human CRC. Our results describe a new activity of IL-22 in the colon as a nonredundant mediator of the inflammatory cascade required for perpetuation of CRC, highlighting the IL-22 axis as a novel therapeutic target in colon cancer.

18 January 2016 in eLife
Verified
Journal Article
Open access
CPClaire Pearson
Claire Pearson
ETEmily E Thornton
Emily E Thornton
BMBrent McKenzie
Brent McKenzie
ASAnna-Lena Schaupp
Anna-Lena Schaupp
NHNicky Huskens
Nicky Huskens
FPFiona Powrie
Fiona Powrie
Innate lymphoid cells (ILCs) contribute to host defence and tissue repair but can induce immunopathology. Recent work has revealed tissue-specific roles for ILCs; however, the question of how a small population has large effects on immune homeostasis remains unclear. We identify two mechanisms that ILC3s utilise to exert their effects within intestinal tissue. ILC-driven colitis depends on production of granulocyte macrophage-colony stimulating factor (GM-CSF), which recruits and maintains intestinal inflammatory monocytes. ILCs present in the intestine also enter and exit cryptopatches in a highly dynamic process. During colitis, ILC3s mobilize from cryptopatches, a process that can be inhibited by blocking GM-CSF, and mobilization precedes inflammatory foci elsewhere in the tissue. Together these data identify the IL-23R/GM-CSF axis within ILC3 as a key control point in the accumulation of innate effector cells in the intestine and in the spatio-temporal dynamics of ILCs in the intestinal inflammatory response.

1 March 2014 in Immunity
Verified
Journal Article
Closed access
SDSteven J. Van Dyken
Steven J. Van Dyken
AMAlexander Mohapatra
Alexander Mohapatra
JNJesse C. Nussbaum
Jesse C. Nussbaum
AMAri B. Molofsky
Ari B. Molofsky
ETEmily E. Thornton
Emily E. Thornton
RLRichard M. Locksley
Richard M. Locksley

14 May 2012 in Journal of Experimental Medicine
Verified
Journal Article
Open access
ETEmily E. Thornton
Emily E. Thornton
MLMark R. Looney
Mark R. Looney
OBOishee Bose
Oishee Bose
DSDebasish Sen
Debasish Sen
DSDean Sheppard
Dean Sheppard
MKMatthew F. Krummel
Matthew F. Krummel
Asthma pathogenesis is focused around conducting airways. The reasons for this focus have been unclear because it has not been possible to track the sites and timing of antigen uptake or subsequent antigen presentation to effector T cells. In this study, we use two-photon microscopy of the lung parenchyma and note accumulation of CD11b+ dendritic cells (DCs) around the airway after allergen challenge but very limited access of these airway-adjacent DCs to the contents of the airspace. In contrast, we observed prevalent transepithelial uptake of particulate antigens by alveolar DCs. These distinct sites are temporally linked, as early antigen uptake in alveoli gives rise to DC and antigen retention in the airway-adjacent region. Antigen-specific T cells also accumulate in the airway-adjacent region after allergen challenge and are activated by the accumulated DCs. Thus, we propose that later airway hyperreactivity results from selective retention of allergen-presenting DCs and antigen-specific T cells in airway-adjacent interaction zones, not from variation in the abilities of individual DCs to survey the lung.

28 March 2022 in Immunity
Verified
Journal Article
Open access
AMAndrew J. MacLean
Andrew J. MacLean
NRNiamh Richmond
Niamh Richmond
LKLada Koneva
Lada Koneva
MAMoustafa Attar
Moustafa Attar
CMCesar A.P. Medina
Cesar A.P. Medina
TATal I. Arnon
Tal I. Arnon
Resident memory B (BRM) cells develop and persist in the lungs of influenza-infected mice and humans; however, their contribution to recall responses has not been defined. Here, we used two-photon microscopy to visualize BRM cells within the lungs of influenza -virus immune and reinfected mice. Prior to re-exposure, BRM cells were sparsely scattered throughout the tissue, displaying limited motility. Within 24 h of rechallenge, these cells increased their migratory capacity, localized to infected sites, and subsequently differentiated into plasma cells. Alveolar macrophages mediated this process, in part by inducing expression of chemokines CXCL9 and CXCL10 from infiltrating inflammatory cells. This led to the recruitment of chemokine receptor CXCR3-expressing BRM cells to infected regions and increased local antibody concentrations. Our study uncovers spatiotemporal mechanisms that regulate lung BRM cell reactivation and demonstrates their capacity to rapidly deliver antibodies in a highly localized manner to sites of viral replication.